These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 17717633)

  • 1. Tumour vascularization: sprouting angiogenesis and beyond.
    Hillen F; Griffioen AW
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):489-502. PubMed ID: 17717633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor reduces mural cell coverage of endothelial cells and induces sprouting rather than luminal division in an HT1080 tumour angiogenesis model.
    Fujimoto A; Onodera H; Mori A; Isobe N; Yasuda S; Oe H; Yonenaga Y; Tachibana T; Imamura M
    Int J Exp Pathol; 2004 Dec; 85(6):355-64. PubMed ID: 15566432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor cell-mediated neovascularization and lymphangiogenesis contrive tumor progression and cancer metastasis.
    Cao Z; Shang B; Zhang G; Miele L; Sarkar FH; Wang Z; Zhou Q
    Biochim Biophys Acta; 2013 Dec; 1836(2):273-86. PubMed ID: 23933263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of human tumour-associated dendritic cells into endothelial-like cells: an alternative pathway of tumour angiogenesis.
    Gottfried E; Kreutz M; Haffner S; Holler E; Iacobelli M; Andreesen R; Eissner G
    Scand J Immunol; 2007 Apr; 65(4):329-35. PubMed ID: 17386023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tumor angiogenesis].
    Bikfalvi A
    Bull Cancer; 2007; 94(7 Suppl):F193-8. PubMed ID: 17964996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of tumor vascularization.
    Auguste P; Lemiere S; Larrieu-Lahargue F; Bikfalvi A
    Crit Rev Oncol Hematol; 2005 Apr; 54(1):53-61. PubMed ID: 15780907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rationale of antiangiogenic therapy].
    Tímár J; Paku S; Tóvári J; Döme B
    Magy Onkol; 2006; 50(2):141-51. PubMed ID: 16888678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling the role of angiogenesis and vasculogenesis in solid tumour growth.
    Stamper IJ; Byrne HM; Owen MR; Maini PK
    Bull Math Biol; 2007 Nov; 69(8):2737-72. PubMed ID: 17874270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signalling pathways in vasculogenic mimicry.
    Paulis YW; Soetekouw PM; Verheul HM; Tjan-Heijnen VC; Griffioen AW
    Biochim Biophys Acta; 2010 Aug; 1806(1):18-28. PubMed ID: 20079807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mast cells and tumour angiogenesis: new insight from experimental carcinogenesis.
    Crivellato E; Nico B; Ribatti D
    Cancer Lett; 2008 Sep; 269(1):1-6. PubMed ID: 18450371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mathematical model of tumour angiogenesis, regulated by vascular endothelial growth factor and the angiopoietins.
    Plank MJ; Sleeman BD; Jones PF
    J Theor Biol; 2004 Aug; 229(4):435-54. PubMed ID: 15246783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour vascularisation: a druggable target.
    Bishop-Bailey D
    Curr Opin Pharmacol; 2009 Apr; 9(2):96-101. PubMed ID: 19056315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role and therapeutic potential of endothelial progenitor cells in tumor neovascularization.
    Janic B; Arbab AS
    ScientificWorldJournal; 2010 Jun; 10():1088-99. PubMed ID: 20563532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumours can adapt to anti-angiogenic therapy depending on the stromal context: lessons from endothelial cell biology.
    van Kempen LC; Leenders WP
    Eur J Cell Biol; 2006 Feb; 85(2):61-8. PubMed ID: 16439306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological angiogenesis: mechanisms and therapeutic strategies.
    Dudley AC; Griffioen AW
    Angiogenesis; 2023 Aug; 26(3):313-347. PubMed ID: 37060495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intussusceptive angiogenesis: a biologically relevant form of angiogenesis.
    De Spiegelaere W; Casteleyn C; Van den Broeck W; Plendl J; Bahramsoltani M; Simoens P; Djonov V; Cornillie P
    J Vasc Res; 2012; 49(5):390-404. PubMed ID: 22739226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Escape mechanisms after antiangiogenic treatment, or why are the tumors growing again?
    Hlushchuk R; Makanya AN; Djonov V
    Int J Dev Biol; 2011; 55(4-5):563-7. PubMed ID: 21858777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating endothelial cells, bone marrow-derived endothelial progenitor cells and proangiogenic hematopoietic cells in cancer: From biology to therapy.
    Dome B; Timar J; Ladanyi A; Paku S; Renyi-Vamos F; Klepetko W; Lang G; Dome P; Bogos K; Tovari J
    Crit Rev Oncol Hematol; 2009 Feb; 69(2):108-24. PubMed ID: 18768327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspectives on lymphangiogenesis and angiogenesis in cancer.
    Holopainen T; Bry M; Alitalo K; Saaristo A
    J Surg Oncol; 2011 May; 103(6):484-8. PubMed ID: 21480240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Circulating endothelial cells: biomarkers for monitoring activity of antiangiogenic therapy].
    Farace F; Bidart JM
    Bull Cancer; 2007 Jul; 94 Spec No():S254-9. PubMed ID: 17846012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.